Trial Profile
Assessing the Safety and Efficacy of Switching to AZARGA (Brinzolamide/Timolol Fixed Combination) as Replacement Therapy in Patients With Uncontrolled Intraocular Pressure in Taiwan
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Jun 2014
Price :
$35
*
At a glance
- Drugs Brinzolamide/timolol (Primary)
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Therapeutic Use
- Sponsors Alcon
- 18 Jun 2014 New trial record